Fresenius Medical Care AG (FMS) Research & Development (2009 - 2025)

Fresenius Medical Care AG's Research & Development history runs 17 years deep, the most recent figure standing at $45.4 million for Q4 2025.

• In Q4 2025, Research & Development fell 15.03% year-over-year to $45.4 million; the TTM figure through Dec 2025 stood at $177.9 million (down 10.64% YoY), while the FY2025 annual figure was $183.9 million, down 5.95% from the prior year.
• Research & Development was $45.4 million for Q4 2025 at Fresenius Medical Care AG, up from $44.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $77.8 million in Q4 2021 to a low of $43.1 million in Q2 2025.
• Historically, Research & Development has averaged $56.4 million across 5 years, with a median of $58.2 million in 2023.
• The sharpest annual moves came in 2021 and 2024: Research & Development rose 25.47% in 2021, then dropped 24.76% in 2024.
• A 5-year view of Research & Development shows it stood at $77.8 million in 2021, then dropped by 18.68% to $63.3 million in 2022, then climbed by 12.26% to $71.0 million in 2023, then slipped by 24.76% to $53.4 million in 2024, then fell by 15.03% to $45.4 million in 2025.
• The last three Research & Development figures came in at $45.4 million (Q4 2025), $44.1 million (Q3 2025), and $43.1 million (Q2 2025), per Business Quant data.